GB0808017D0 - shRHA sequences - Google Patents

shRHA sequences

Info

Publication number
GB0808017D0
GB0808017D0 GB0808017A GB0808017A GB0808017D0 GB 0808017 D0 GB0808017 D0 GB 0808017D0 GB 0808017 A GB0808017 A GB 0808017A GB 0808017 A GB0808017 A GB 0808017A GB 0808017 D0 GB0808017 D0 GB 0808017D0
Authority
GB
United Kingdom
Prior art keywords
shrha
sequences
shrha sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0808017A
Other versions
GB2448994A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos NV filed Critical Galapagos NV
Publication of GB0808017D0 publication Critical patent/GB0808017D0/en
Publication of GB2448994A publication Critical patent/GB2448994A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/12—Applications; Uses in screening processes in functional genomics, i.e. for the determination of gene function
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised
    • C12N2330/31—Libraries, arrays

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB0808017A 2007-05-04 2008-05-02 shRNA sequences Withdrawn GB2448994A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0708662A GB0708662D0 (en) 2007-05-04 2007-05-04 shRNA sequences

Publications (2)

Publication Number Publication Date
GB0808017D0 true GB0808017D0 (en) 2008-06-11
GB2448994A GB2448994A (en) 2008-11-05

Family

ID=38198755

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0708662A Ceased GB0708662D0 (en) 2007-05-04 2007-05-04 shRNA sequences
GB0808017A Withdrawn GB2448994A (en) 2007-05-04 2008-05-02 shRNA sequences

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB0708662A Ceased GB0708662D0 (en) 2007-05-04 2007-05-04 shRNA sequences

Country Status (1)

Country Link
GB (2) GB0708662D0 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ553126A (en) * 2004-08-09 2010-11-26 Bionomics Ltd Compositions and methods for angiogenesis related molecules and treatments
WO2006047635A2 (en) * 2004-10-27 2006-05-04 Wen-Tien Chen Methods and compositions for seprase inactivation
DK2172549T3 (en) * 2005-02-03 2015-11-02 Benitec Inc RNAi-ekspressionskonstrukter
US8394742B2 (en) * 2005-04-15 2013-03-12 The Translation Genomics Research Institute Methods, compounds and compositions with genotype selective anticancer activity
US20090210955A1 (en) * 2005-06-09 2009-08-20 Artemis Pharmaceuticals Gmbh Shrna and sirna expression in a living organism under control of a codon-optimized repressor gene
US20090047338A1 (en) * 2005-10-05 2009-02-19 Immune Disease Institute, Inc. Method to Treat Flavivirus Infection with siRNA
WO2008016391A2 (en) * 2006-01-31 2008-02-07 The Board Of Trustees Of The Leland Stanford Junior University Self-complementary parvoviral vectors, and methods for making and using the same
WO2007137239A2 (en) * 2006-05-19 2007-11-29 The Scripps Research Institute Treatment of protein misfolding
WO2007137129A2 (en) * 2006-05-19 2007-11-29 Alcon Research, Ltd. RNAI-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR α-RELATED CONDITIONS
US20080051361A1 (en) * 2006-08-24 2008-02-28 Alcon Manufacturing, Ltd. Rnai-mediated inhibition of gremlin for treatment of iop-related conditions

Also Published As

Publication number Publication date
GB2448994A (en) 2008-11-05
GB0708662D0 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
GB0706709D0 (en) Methods
AP2010005314A0 (en) Nanodispersian
GB0718160D0 (en) Methods
GB0721136D0 (en) Fence-pal
GB2445940B (en) Electro-chlorinator
GB0704817D0 (en) Railbond
GB0723387D0 (en) Improved dehumldifier
GB0704693D0 (en) Multi-plough
GB0715502D0 (en) Methods
GB0714842D0 (en) Methods
GB0707735D0 (en) Methods
GB0719252D0 (en) Methods
GB0713673D0 (en) Methods
GB0808017D0 (en) shRHA sequences
TWI366846B (en) Recitiformer
AU3606P (en) Jaywick xTriticosecale
GB0715962D0 (en) Time
GB0715542D0 (en) Methods
GB0701417D0 (en) Methods
GB0724222D0 (en) Methods
GB0722035D0 (en) Methods
GB0700966D0 (en) Methods
GB0712401D0 (en) Methods
GB0713281D0 (en) Methods
GB0714265D0 (en) Methods

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)